No FDA approved human use
Body weight reduction was 10.7% correcting for the small weight loss in the placebo group
The purity assessment criteria for research-grade materials are generally much less rigorous, partially incomplete, and/or poorly followed, per a 2014 paper.21 Additionally, while some studies state that BPC-157 has good oral bioavailability based on its stability in human gastric juice, little if any research has investigated the differences in bioavailability between BPC-157 routes of administration.22 We could find only a single rat study that used oral BPC-157.23 So the best option would be an injectable form of BPC-157 from a reputable clinic
If you have kidney disease, make sure to discuss this with your healthcare provider
Proper Dosing While IV therapy allows for higher vitamin C intake than oral supplements, excessively high doses may not always provide additional benefits
Specific microbial taxa, functional pathways, and hostmicrobe interactions have been associated with differential metabolic responses to GLP-1 RA therapy ( One of the most informative human studies in this field is one pilot trial, which demonstrated that patients achieving robust glycemic improvements following GLP-1 RA therapy displayed a distinct baseline microbial profile characterized by greater -diversity and enrichment of SCFAproducing bacteria, including Roseburia inulinivorans , Lachnoclostridium spp., Butyricicoccus , and Faecalibacterium prausnitzii ( Table 2